Diabetic Therapy
VILTROY M
Vildagliptin (500mg+50mg) + Metformin HCL
Dosage Form
Tablets
Packing
10*15 ALU
MRP
₹1950
Prescribed By
Diabetologist, Endocrinologist, General Physician, Internal Medicine, Family Medicine
Quick Facts
Form
Tablets
Pack
10×15 ALU
MRP
₹1950
Prescribed By
Diabetologist, Endocrinologist, General Physician
Key Benefits
01
Vildagliptin + Metformin — proven dual-mechanism combination.
02
Safe in mild to moderate kidney disease.
03
Low hypoglycaemia risk.
04
Convenient single daily tablet.
Mechanism of Action
Vildagliptin enhances insulin secretion via DPP-4 inhibition. Metformin reduces hepatic glucose production and improves insulin sensitivity. Together they provide complementary blood sugar control.
Indications
Type 2 diabetes inadequately controlled on Metformin alone.
Dosage & Administration
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
Why VILTROY M?
VILTROY M combines Vildagliptin's glucose-dependent insulin stimulation with Metformin's insulin-sensitising effect — a safe, well-tolerated step-up from Metformin monotherapy.
